Join us on Wednesday, September 2nd from 1:00pm – 2:15pm EDT for our second webinar on allometric scaling, which will focus on pediatric drug development. Nuventra’s Senior Consultant and former FDA Reviewer, Iftekhar Mahmood, Ph.D., will lead the session titled, “Pediatric Drug Development: Allometry and Other Empirical Models.”
This webinar will cover an introduction of pediatric drug development using allometric scaling and other empirical models. Other empirical models will include Physiologically-Based Pharmacokinetics (PBPK) and Population PK (popPK). At the end of this webinar attendees should have a better understanding of:
- Allometry and its appropriate application to pediatric drug development
- Simplicity of allometric scaling in comparison to other complex empirical models
- Dose selection for first-in-pediatric clinical trials
Meet the Presenter
Iftekhar Mahmood, Ph.D.
Senior Consultant, Clinical Pharmacology and Pharmacometrics
Dr. Mahmood has more than 25 years of experience in clinical pharmacology with the FDA. He worked both in the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). At the FDA, besides his review duties, Dr. Mahmood was involved with clinical pharmacology research (both small and large molecules) and published more than 100 research papers in peer-reviewed scientific journals. His research mainly focused on allometric scaling, modeling, sparse sampling, and pediatric drug development.